 | Up a level |
Naimi, Adel and Mohammed, Rebar N. and Raji, Ahmed and Chupradit, Supat and Valerievich Yumashev, Alexei and Suksatan, Wanich and Shalaby, Mohammed Nader and Thangavelu, Lakshmi and Kamrava, Siavash and Shomali, Navid and Sohrabi, Armin D. and Adili, Ali and Noroozi-Aghideh, Ali and Razeghian, Ehsan (2022) Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell communication and signaling.
Marofi, Faroogh and Marwan Mahmood Saleh, Marwan Mahmood and Rahman, Heshu Sulaiman and Suksatan, Wanich and E. Al-Gazally, Moaed and Abdelbasset, Walid Kamal and Thangavelu, Lakshmi and Valerievich Yumashev, Alexei and Hassanzadeh, Ali and Yazdanifar, Mahboubeh and Motavalli, Roza and Pathak, Yashwant and Naimi, Adel and Baradaran, Behzad and Nikoo, Marzieh and Motavalli Khiavi, Farhad (2021) CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies. Stem Cell Research and Therapy.
